Current List Prices
Wegovy (semaglutide 2.4 mg for weight loss) has a list price of about $1,349 per month for a four-week supply. Ozempic (semaglutide 0.5-2 mg for diabetes) lists at around $935 per month. This makes Wegovy roughly 44% more expensive at full price.[1][2]
Why the Price Gap Exists
Wegovy delivers a higher weekly dose (2.4 mg vs. Ozempic's max 2 mg), requiring more drug per pen, which drives up manufacturing costs. Novo Nordisk positions Wegovy for obesity as a distinct product from Ozempic for type 2 diabetes, with separate FDA approvals and marketing. Insurance often covers Ozempic more readily for diabetes but limits Wegovy for weight loss.[3]
With Insurance and Discounts
- Commercial insurance: Ozempic copays average $25-50/month; Wegovy can hit $100-300 or more if covered, as many plans exclude weight-loss drugs. Novo Nordisk's savings cards cap out-of-pocket at $25 for up to 13 fills on either (income-qualified).[1][4]
- Medicare: Neither is typically covered for weight loss; Ozempic may be for diabetes at $100-400/month after Part D.
- Uninsured/cash pay: Compounding pharmacies offer semaglutide versions for $200-500/month, undercutting both but with quality risks.[2]
Net difference shrinks to $0-200/month for insured patients, but Wegovy users pay more without weight-loss coverage.
Monthly Cost Comparison Table
| Scenario | Ozempic (est. monthly) | Wegovy (est. monthly) | Difference |
|-----------------------|------------------------|-----------------------|------------|
| List price | $935 | $1,349 | +$414 |
| With savings card | $25 | $25 | $0 |
| Commercial insurance (diabetes/weight OK) | $30-60 | $100-300 | +$70-240 |
| Compounded alternative| $250-400 | N/A (dose-specific) | N/A |
Prices from 2024 data; vary by pharmacy, dose, and location.[1][2][5]
Factors Driving Future Changes
Shortages have eased, but high demand keeps prices elevated. Patents on semaglutide expire around 2031-2032 in the US, opening doors for generics or biosimilars that could halve costs.[6] Eli Lilly's Zepbound (tirzepatide) lists at $1,060/month, sometimes cheaper with coverage than Wegovy.
[1]: Drugs.com - Ozempic Pricing
[2]: Drugs.com - Wegovy Pricing
[3]: Novo Nordisk investor reports
[4]: Novo Nordisk Savings Card
[5]: GoodRx averages, Sept 2024
[6]: DrugPatentWatch.com - Semaglutide Patents